Skip to Content

Thiamine Injection

Last Updated: June 2, 2021
Status: Resolved

Reason for the Shortage
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional did not provide a reason for the shortage.
    • Sagent had thiamine injection on shortage due to manufacturing delays.
Available Products
    • Thiamine injection, Fresenius Kabi, 100 mg/mL, 2 mL vial, 25 count, NDC 63323-0013-02
    • Thiamine injection, Hikma, 100 mg/mL, 2 mL vial, 25 count, NDC 00641-6228-25
    • Thiamine injection, Mylan Institutional, 100 mg/mL, 2 mL vial, 25 count, NDC 67457-0196-02
    • Thiamine injection, Sagent, 100 mg/mL, 2 mL vial, 25 count, NDC 25021-0500-02

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated June 2, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created December 13, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.